Director – Individual Non-Participating Life Products

Knowledge of a broad area of expertise (by product and by function) gained through 10+ years of directly or indirectly related work experience and training in Life
Strong analytical and problem solving skills, with the ability to be an innovative thinker and understand the ‘big picture’
Analytical skills, preferably actuarial designation (FSA/FCIA/CERA) and IFRS 17 experience
Ability and willingness to partner effectively with other actuarial leaders, as well as with leaders of other functional areas
Ability to see business issues from multiple angles, recognize ‘flags’ that indicate a need for analysis and then communicate the analysis in a manner that is effective and understandable to the particular audience.

Lead and enhance annual experience study including participating in industry studies. Streamline the study process, interpret emerging results, and propose new assumptions for valuation and actionable items for the business. Comply with SoX controls and EUC requirements.
Review and enhance actuarial financial reporting for the individual non-participating life business, including but not limited to: Month-end/Quarter-end process and AA Report. In addition, provide the business with implications of emerging financial results and related metrics, particularly earning by sources (EBS), mortality, lapse, etc.
Support risk governance and oversight, including annual update of risk appetite and risk control limits, and ensure top and emerging risks remain within risk appetite through frequent monitoring.
Provide senior management and the business with in-depth analysis and understanding of emerging risks and action items.
Work closely with the business and other functional partners on strategic projects and tactical actions, and assist these areas in achieving their goals.
Manage a team of staff including providing focus and clarity in establishing individual goals, driving performance management, supporting career development and rewarding strong performance.